139 related articles for article (PubMed ID: 10705912)
1. Mood states associated with transitory changes in asthma symptoms and peak expiratory flow.
Affleck G; Apter A; Tennen H; Reisine S; Barrows E; Willard A; Unger J; ZuWallack R
Psychosom Med; 2000; 62(1):61-8. PubMed ID: 10705912
[TBL] [Abstract][Full Text] [Related]
2. Perception of airway obstruction in asthma: sequential daily analyses of symptoms, peak expiratory flow rate, and mood.
Apter AJ; Affleck G; Reisine ST; Tennen HA; Barrows E; Wells M; Willard A; ZuWallack RL
J Allergy Clin Immunol; 1997 May; 99(5):605-12. PubMed ID: 9155825
[TBL] [Abstract][Full Text] [Related]
3. Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks.
Humbert M; Robinson DS; Assoufi B; Kay AB; Durham SR
Thorax; 1996 Jul; 51(7):664-9. PubMed ID: 8882070
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of asthma control using patient based measures and peak expiratory flow rate.
Pinto Pereira LM; Boodoo S; Dindial KA; Hosein A; Seemungal TA; Bekele I
West Indian Med J; 2009 Jun; 58(3):214-8. PubMed ID: 20043527
[TBL] [Abstract][Full Text] [Related]
5. Peak expiratory flow rate and symptom self-monitoring of asthma initiated from community pharmacies.
Bheekie A; Syce JA; Weinberg EG
J Clin Pharm Ther; 2001 Aug; 26(4):287-96. PubMed ID: 11493372
[TBL] [Abstract][Full Text] [Related]
6. A randomized clinical trial of magnesium sulphate as a vehicle for nebulized salbutamol in the treatment of moderate to severe asthma attacks.
Kokturk N; Turktas H; Kara P; Mullaoglu S; Yilmaz F; Karamercan A
Pulm Pharmacol Ther; 2005; 18(6):416-21. PubMed ID: 15953743
[TBL] [Abstract][Full Text] [Related]
7. Clinically meaningful changes in quantitative measures of asthma severity.
Karras DJ; Sammon ME; Terregino CA; Lopez BL; Griswold SK; Arnold GK
Acad Emerg Med; 2000 Apr; 7(4):327-34. PubMed ID: 10805619
[TBL] [Abstract][Full Text] [Related]
8. Peak expiratory flow rate and premenstrual symptoms in healthy nonasthmatic women.
Chong E; Ensom MH
Pharmacotherapy; 2000 Dec; 20(12):1409-16. PubMed ID: 11130212
[TBL] [Abstract][Full Text] [Related]
9. [A comparative study of clinical score and lung function tests in the classification of asthma by severity of disease].
Nakaie CM; Rozov T; Manissadjian A
Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(2):68-74. PubMed ID: 9699357
[TBL] [Abstract][Full Text] [Related]
10. The effect of inhaled albuterol in moderate to severe asthma.
Apter AJ; Reisine ST; Willard A; Clive J; Wells M; Metersky M; McNally D; ZuWallack RL
J Allergy Clin Immunol; 1996 Aug; 98(2):295-301. PubMed ID: 8757206
[TBL] [Abstract][Full Text] [Related]
11. Observations on the effects of aerosolized albuterol in acute asthma.
Strauss L; Hejal R; Galan G; Dixon L; McFadden ER
Am J Respir Crit Care Med; 1997 Feb; 155(2):454-8. PubMed ID: 9032178
[TBL] [Abstract][Full Text] [Related]
12. Peak expiratory flow rate underestimates severity of airflow obstruction in acute asthma.
Choi IS; Koh YI; Lim H
Korean J Intern Med; 2002 Sep; 17(3):174-9. PubMed ID: 12298428
[TBL] [Abstract][Full Text] [Related]
13. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
14. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
[TBL] [Abstract][Full Text] [Related]
15. Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: a randomized clinical trial.
Lin RY; Pesola GR; Bakalchuk L; Morgan JP; Heyl GT; Freyberg CW; Cataquet D; Westfal RE
Ann Emerg Med; 1998 Feb; 31(2):208-13. PubMed ID: 9472182
[TBL] [Abstract][Full Text] [Related]
16. Adequacy of control of asthma in a general practice. Is maximum peak expiratory flow rate a valid index of asthma severity?
Morris NV; Abramson MJ; Strasser RP
Med J Aust; 1994 Jan; 160(2):68-71. PubMed ID: 8309371
[TBL] [Abstract][Full Text] [Related]
17. The effect of bronchodilators on diurnal rhythms in airway obstruction.
Connolly CK
Br J Dis Chest; 1981 Apr; 75(2):197-203. PubMed ID: 7196770
[TBL] [Abstract][Full Text] [Related]
18. Should we monitor peak expiratory flow rates or record symptoms with a simple diary in the management of asthma?
Malo JL; L'Archevêque J; Trudeau C; d'Aquino C; Cartier A
J Allergy Clin Immunol; 1993 Mar; 91(3):702-9. PubMed ID: 8454792
[TBL] [Abstract][Full Text] [Related]
19. Daily psychosocial factors predict levels and diurnal cycles of asthma symptomatology and peak flow.
Smyth JM; Soefer MH; Hurewitz A; Kliment A; Stone AA
J Behav Med; 1999 Apr; 22(2):179-93. PubMed ID: 10374142
[TBL] [Abstract][Full Text] [Related]
20. Effect of out-of-hospital albuterol inhalation treatments on patient comfort and morbidity.
Weiss SJ; Anand P; Ernst AA; Orgeron D; May WL
Ann Emerg Med; 1994 Nov; 24(5):873-8. PubMed ID: 7978560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
